Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.01

-2.9%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (16947)	3/9/1998 3:59:00 PM
From: Arthur Radley	Read Replies (1) of 32384

Henry, This is probably stretching LGND's capability but I thought I would ask anyway. Over the weekend I caught the end of a medical report about the use of Taxol for patients who had undergone angioplasty surgery. It was my understanding that Taxol was being used to keep the arteries open after the surgery for a longer period of time. My question, isn't Tamoxifen really Taxol, and with the recent study comparing Targretin to Tamoxifen for breast cancer, is there any possibility that Targretin would have the same capability with angioplasty patients?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next